117 related articles for article (PubMed ID: 10987990)
41. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.
Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648
[TBL] [Abstract][Full Text] [Related]
42. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes.
Gokoh M; Kishimoto S; Oka S; Metani Y; Sugiura T
FEBS Lett; 2005 Nov; 579(28):6473-8. PubMed ID: 16288744
[TBL] [Abstract][Full Text] [Related]
43. The endogenous cannabinoid system and the treatment of marijuana dependence.
Piomelli D
Neuropharmacology; 2004; 47 Suppl 1():359-67. PubMed ID: 15464150
[TBL] [Abstract][Full Text] [Related]
44. A new endothelial target for cannabinoids.
Randall MD
Mol Pharmacol; 2003 Mar; 63(3):469-70. PubMed ID: 12606752
[No Abstract] [Full Text] [Related]
45. Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1.
Chen Y; McCarron RM; Ohara Y; Bembry J; Azzam N; Lenz FA; Shohami E; Mechoulam R; Spatz M
Circ Res; 2000 Aug; 87(4):323-7. PubMed ID: 10948067
[TBL] [Abstract][Full Text] [Related]
46. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain.
Nakane S; Oka S; Arai S; Waku K; Ishima Y; Tokumura A; Sugiura T
Arch Biochem Biophys; 2002 Jun; 402(1):51-8. PubMed ID: 12051682
[TBL] [Abstract][Full Text] [Related]
47. Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability.
Parkkari T; Myllymäki M; Savinainen JR; Saario SM; Castillo-Meléndez JA; Laitinen JT; Nevalainen T; Koskinen AM; Järvinen T
Bioorg Med Chem Lett; 2006 May; 16(9):2437-40. PubMed ID: 16466915
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide modulates the inhibitory effect of cannabinoids on the immunological activation of guinea pig mast cells.
Vannacci A; Passani MB; Pierpaoli S; Giannini L; Mannaioni PF; Masini E
Inflamm Res; 2003 Apr; 52 Suppl 1():S07-8. PubMed ID: 12755386
[No Abstract] [Full Text] [Related]
49. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.
Panikashvili D; Simeonidou C; Ben-Shabat S; Hanus L; Breuer A; Mechoulam R; Shohami E
Nature; 2001 Oct; 413(6855):527-31. PubMed ID: 11586361
[TBL] [Abstract][Full Text] [Related]
50. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells.
Opitz CA; Rimmerman N; Zhang Y; Mead LE; Yoder MC; Ingram DA; Walker JM; Rehman J
FEBS Lett; 2007 Oct; 581(25):4927-31. PubMed ID: 17904123
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues.
Bilfinger TV; Salzet M; Fimiani C; Deutsch DG; Tramu G; Stefano GB
Int J Cardiol; 1998 Apr; 64 Suppl 1():S15-22. PubMed ID: 9687088
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release.
Stefano GB; Salzet B; Salzet M
Brain Res; 1997 Apr; 753(2):219-24. PubMed ID: 9125406
[TBL] [Abstract][Full Text] [Related]
53. Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG).
McCarron RM; Shohami E; Panikashvili D; Chen Y; Golech S; Strasser A; Mechoulam R; Spatz M
Acta Neurochir Suppl; 2003; 86():271-5. PubMed ID: 14753451
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE).
Parkkari T; Salo OM; Huttunen KM; Savinainen JR; Laitinen JT; Poso A; Nevalainen T; Järvinen T
Bioorg Med Chem; 2006 Apr; 14(8):2850-8. PubMed ID: 16403642
[TBL] [Abstract][Full Text] [Related]
55. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release.
Fimiani C; Mattocks D; Cavani F; Salzet M; Deutsch DG; Pryor S; Bilfinger TV; Stefano GB
Cell Signal; 1999 Mar; 11(3):189-93. PubMed ID: 10353693
[TBL] [Abstract][Full Text] [Related]
56. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.
Ben-Shabat S; Fride E; Sheskin T; Tamiri T; Rhee MH; Vogel Z; Bisogno T; De Petrocellis L; Di Marzo V; Mechoulam R
Eur J Pharmacol; 1998 Jul; 353(1):23-31. PubMed ID: 9721036
[TBL] [Abstract][Full Text] [Related]
57. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid.
Mechoulam R; Fride E; Ben-Shabat S; Meiri U; Horowitz M
Eur J Pharmacol; 1998 Nov; 362(1):R1-3. PubMed ID: 9865537
[TBL] [Abstract][Full Text] [Related]
58. Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
Prieto D
Eur Urol; 2010 Feb; 57(2):349. PubMed ID: 19147273
[No Abstract] [Full Text] [Related]
59. Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2.
Jorda MA; Rayman N; Valk P; De Wee E; Delwel R
Ann N Y Acad Sci; 2003 May; 996():10-6. PubMed ID: 12799277
[TBL] [Abstract][Full Text] [Related]
60. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Mechoulam R; Ben-Shabat S; Hanus L; Ligumsky M; Kaminski NE; Schatz AR; Gopher A; Almog S; Martin BR; Compton DR
Biochem Pharmacol; 1995 Jun; 50(1):83-90. PubMed ID: 7605349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
